Catalyst Wire Dossier Catalyst Wire Dossier

Vesatolimod

vesatolimod · Gilead Sciences
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Vesatolimod, covering 2020-02-21 to 2026-01-16. Get the full timeline:

Most recent: Clinical Trial Update: Study of VRC07-523LS, CAP256V2LS, and Vesatolimod, in Early Antiretroviral-treated HIV-1 Clade C-infected Women [Phase 2]

See pricing